Terumo Cardiovascular Group (Terumo CV Group) introduces the newest addition to the CAPIOX Oxygenator portfolio – the CAPIOX FX Advance Oxygenator. The CAPIOX FX Advance replaces the current CAPIOX FX15 and FX25 line of oxygenators manufactured in Elkton, Maryland.
Enhancements to the CAPIOX FX Advance include improved flow dynamics with an increased blood flow rate on the 3,000 mL reservoir – available on the FX15 Advance Oxygenator – and a lower minimum operating level on the 4,000 mL reservoir – available on the FX15 and FX25 Advance Oxygenators. The CAPIOX FX Advance helps clinicians further reduce prime volume and lower hemodilution, allowing them to choose a smaller, lower prime oxygenator for even more patients.
To preview the CAPIOX FX Advance oxygenator, visit the Terumo booth at these 2016 U.S. conferences:
- CREF – February 24-27
- AmSECT – March 15-19
- Sanibel Symposium – April 20-23
- American Association for Thoracic Surgery (AATS) – May 14-18
- Mechanisms of Perfusion – May 19-22
For more information about CAPIOX FX Advance Oxygenators, visit http://www.terumo-cvs.com/fxadvance
Terumo Cardiovascular Group